Receptor desensitization is the primary reason
income level (retrieved from the pharmaceutical copayment system that establishes different levels of copayment based on the following income categories: people earning less than 18,000/year, 18,000 to 100,000/year, more than 100,000/year, population exempt from copayment due to socioeconomic vulnerability (labelled in our study as the low resources group), and people without income data (labelled as not available)
Be alert for symptoms like jaundice, fatigue, and abdominal pain
Saving $20 on a vial while injecting unknown substances is not a reasonable tradeoff
Kelishadi was direct about which patients are appropriate candidates
(There are FDA application-fee discounts and certain tax benefits for the research and development costs associated with a drug that is designated an Orphan Drug.) The designation does not mean the medication is FDA approved, and until it is approved, a pharmacy may not compound derivatives